Maruyama Yasuhiro, Fukushima Toshirou, Gomi Daisuke, Kobayashi Takashi, Sekiguchi Nodoka, Sakamoto Akiyuki, Sasaki Shigeru, Mamiya Keiko, Koizumi Tomonobu
Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Second Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano 390-8621, Japan.
Mol Clin Oncol. 2017 Oct;7(4):521-524. doi: 10.3892/mco.2017.1383. Epub 2017 Aug 18.
A 63-year-old female patient who had undergone cholecystectomy for inflammatory myofibroblastic tumor (IMT) in the gallbladder was referred to our hospital. The patient's disease relapsed, involving the pancreas, and was diagnosed as inoperable IMT 13 months after the cholecystectomy. The patient failed to respond to steroid and non-steroidal anti-inflammatory drug therapy, but subsequently exhibited a good response to vinorelbine and methotrexate combination chemotherapy. Little information is currently available on the efficacy of chemotherapy for adult-onset IMT. The present case suggests that chemotherapy with vinorelbine and methotrexate is a viable therapeutic option for adult patients with unresectable IMT.
一名63岁女性患者因胆囊炎性肌纤维母细胞瘤(IMT)接受了胆囊切除术,之后转诊至我院。患者疾病复发,累及胰腺,在胆囊切除术后13个月被诊断为无法手术切除的IMT。患者对类固醇和非甾体抗炎药治疗无效,但随后对长春瑞滨和甲氨蝶呤联合化疗表现出良好反应。目前关于成人IMT化疗疗效的信息很少。本病例表明,长春瑞滨和甲氨蝶呤联合化疗是成人不可切除IMT患者的一种可行治疗选择。